Call for Abstract

32nd Annual Cardiologists Conference, will be organized around the theme “Insights of Cardiology & Healthcare”

Cardiologists 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Cardiologists 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Cardiac nursing is a special nursing field which works with patients who suffer from different conditions of the cardiovascular system. Cardiac nurses help treat and care conditions such as unstable angina, cardiomyopathy, Coronary Artery Disease, Congestive Heart Failure, infarction of myocardium and cardiac arrhythmia under the direction of a cardiologist. Cardiac nurses perform post-operative treatment on a surgical unit, stress test evaluations, cardiac monitoring, vascular monitoring, and health evaluations

 

  • Track 1-1Cardiac rehabilitation nursing
  • Track 1-2Cardiac Nursing assesment
  • Track 1-3Cardiac catheterization
  • Track 1-4Congestive Heart Failure
  • Track 1-5Quality and safety of nursing care
  • Track 1-6Cardiac Dysrhythmia

 Cardiovascular Surgery is the main surgery on the heart vessels. It is employed to treat the complications of valvular heart disease, ischemic heart disease or to correct Congenital Heart Disease  from various causes, endocarditis, atherosclerosisRheumatic Heart Disease. It also includes heart transplantation.

 

  • Track 2-1Open heart surgery
  • Track 2-2Cardiothoracic surgery
  • Track 2-3Bypass surgery
  • Track 2-4Pediatric cardiovascular surgery
  • Track 2-5Risk of cardiac surgery
  • Track 2-6CV evaluation for non‐cardiac surgery
  • Track 2-7Aortic dissection

Cardio Oncology is characterized as the interdisciplinary field of medication in which the clinical adjustments of Radiation Treatment to the chest is considered as the hazard factors via cardiologists. Different reasons might be the outcomes of radio-and chemo-treatment in long haul overcomers of harm. All patients who are being considered for chemotherapy, particularly the individuals who have earlier history of heart illness ought to experience itemized cardiovascular assessment to enhance the treatment. Sequential examination of left ventricular systolic capacity and cardiovascular biomarkers may likewise be considered in the chosen populaces of patient. Harm can likewise happen amid long haul follow-up after coronary vein sidestep unite (CABG). Cardio-Oncology ponders helps oncologists in early treatment by nearly viewing the core of their patients to ensure them.

 

  • Track 3-1Advanced cancer therapy
  • Track 3-2CV evaluation for non‐cardiac surgery
  • Track 3-3Assessment of Cardiac Tumors
  • Track 3-4Evaluation of New Chemotherapies
  • Track 3-5Evaluation of Long-term Cardiac Risk in Cancer Survivors
  • Track 3-6Observing for Cardiac Complications from Cancer Therapy
  • Track 3-7Hazard Assessment Prior to Cancer Treatment
  • Track 3-8Counteractive action of chemotherapy-prompted cardiovascular brokenness
  • Track 3-9Cardiovascular sarcoma, hemangiosarcoma, angiosarcoma
  • Track 3-10Intra-cardiovascular tumor
  • Track 3-11Malignancy of the heart
  • Track 3-12Aortic dissection

Coronary Heart Disease is also known as the Coronary artery disease which means that the narrowing of the coronary arteries or it is a common term for the buildup of plaque inside the arteries which resize the coronary arteries. After the heart supplies blood with oxygen and nutrients, blood is carried by arteries to different body parts. The coronary arteries are vital: as coronary arteries carry blood to the heart muscle. So, when the coronary arteries become narrower then blood supply reduced to the heart muscles.

 

  • Track 4-1Coronary artery and stroke
  • Track 4-2Carotid artery disease
  • Track 4-3Coronary interventions
  • Track 4-4Coronary thrombosis
  • Track 4-5Aortic aneurysm
  • Track 4-6Acute coronary syndromes
  • Track 4-7Aortic stenosis
  • Track 4-8Aortic regurgitation
  • Track 4-9Coronary care unit
  • Track 4-10Coronary artery atherosclerosis

The regrowth of organs and tissues of the heart that are lost in an injury are called Cardiac Regeneration. This is in disparity to wound healing, which involves closing of the injury site by forming a scar. Few tissues like skin and large organs such as liver regrow quite readily, whilst others have been seen with little or no capacity of regeneration. Nevertheless in the present research, it suggests that particularly in the Lungs and Heart, there is hope for a variety of organs and tissues will eventually develop and the capacity to regenerate.

 

  • Track 5-1Tissue graft cardiac cell replacemen
  • Track 5-2Cardiac remodeling
  • Track 5-3Cardiac regenerative therapy
  • Track 5-4Congenital heart disease and regeneration
  • Track 5-5Heart repair, heart tissue regeneration and stem cells
  • Track 5-6Biomimetic heart valve replacement
  • Track 5-7Stem cell-derived engineered cardiac tissue

Pediatric Cardiology is also called Pediatric Cardiopulmonary disease which involves the childhood disorder includes both the heart and lungs problems. Pediatric cardiologist is a pediatrician who has gotten broad preparing in diagnosis and treatment of kids' Cardiovascular issues. Assessment and treatment may start with the embryo since heart issues can now be identified before birth.

 

  • Track 6-1Innocent murmurs
  • Track 6-2Chest pain
  • Track 6-3Cardiovascular physiology
  • Track 6-4Basic diagnostic studies
  • Track 6-5Clinical evaluation
  • Track 6-6Specific congenital heart defects
  • Track 6-7Acquired heart disease

Cardiovascular pharmacology is the main study of the effects of drugs on the entire Cardiovascular System, which includes the heart and blood vessels.

 

  • Track 7-1Cardiovascular pathology
  • Track 7-2Cardiovascular neoplasm
  • Track 7-3Cardiovascular alteration
  • Track 7-4Cardiovascular disorder
  • Track 7-5Cardiovascular manifestation

Cardiac Remodeling or Ventricular remodeling is generally accepted as a determinant of the clinical course of heart failure (HF). It defines as genome expression resulting in molecular, cellular and interstitial changes and manifested clinically as changes in shape, structure, size, and function of the heart. Cardiac remodeling can happen as a result physiological remodelling or pathological remodeling (injury to the heart muscle) and from cardiac load or injury, cardiac remodeling is influenced by hemodynamic load, neurohormonal activation. Congenital Heart Disease, chronic hypertension, with intra-cardiac shunting, and valvular heart disease may also lead to remodeling. Mostly the cardiac myocyte is the major cell involved in cardiac remodeling. Due to this, the Myocardial Necrosis (cell death) and disproportionate thinning of the heart occurs.

 

  • Track 8-1Hypertensive ventricular remodeling
  • Track 8-2Atrophic remodeling
  • Track 8-3Ventricular remodeling in ischemic heart disease
  • Track 8-4Metabolic remodeling
  • Track 8-5Electrophysiological remodeling
  • Track 8-6Echocardiography or radionuclide imaging

The Vascular Biology exists as a wide-ranging discipline that includes study of vascular function, structure, growth as well as development.  This field comprises investigation at essentially all levels, including studies of molecules, cells, organs also intact organisms.  Perturbations of vascular function be there involved in various pathophysiological states, with Neoplasia, inflammation, aging, neurological diseases, metabolic disorders pulmonary diseases also Hypertension.

 

  • Track 9-1Vascular medicine
  • Track 9-2Vascular surgery
  • Track 9-3Vascular oncology
  • Track 9-4Neurological vascular diseases
  • Track 9-5Vascular interventional radiology
  • Track 9-6Vascular imaging and diagnostic testing
  • Track 9-7Endovascular Intervention
  • Track 9-8Peripheral vascular disease
  • Track 9-9Valvular heart disease
  • Track 9-10Peripheral arterial diseases
  • Track 9-11Left and right atrial thrombus

Cardiomyopathy is a most common group of diseases that affect the heart muscles. In this, the heart muscle becomes rigid, enlarged or thick. In this condition, heart is less able to circulate the blood to all the body parts and maintain a normal electrical rhythm. This can lead to heart failure or irregular heartbeats called arrhythmias. In turn, heart failure can cause fluid to build up in the legs, ankles, lungs, feet or abdomen. The Typical perilous danger in patients with cardiomyopathies is sporadic heart rate.

 

  • Track 10-1Inflammatory cardiomyopathy
  • Track 10-2Dilated cardiomyopathy
  • Track 10-3Idiopathic cardiomyopathy
  • Track 10-4Restrictive cardiomyopathy
  • Track 10-5Myocarditis
  • Track 10-6Diabetic cardiomyopathy

Obesity will increase the chance of cardiopathy and stroke. However, it harms quite simply the guts designation and vessel system. It is also a serious reason behind gallstones, degenerative arthritis, and metabolic process issues. additionally to weight gain may be a frequent consequence of heart-damaging style decisions like lack of exercise & a fat-laden diet. Blubber can also result in serious conditions like a coronary failure, within which your heart can’t pump enough blood to the body. Having a polygenic disease or pre-diabetes puts one at increased risk for cardiopathy and stroke. One will lower its risk by keeping the blood sugar (also known as blood sugar), cardiovascular disease, and blood steroid alcohol near to the counseled target numbers the degree prompt by polygenic disease specialists permanently health. Stroke and coronary cardiopathy will be caused by a similar downside induration of the arteries.

 

  • Track 11-1Diabetes Mellitus and Stroke
  • Track 11-2Abdominal Obesity
  • Track 11-3Vascular dementia
  • Track 11-4Abnormal cholesterol and high triglycerides
  • Track 11-5Haemorrhagic Strokes (Bleeds)
  • Track 11-6Metabolic syndrome

Interventional cardiology is a branch of cardiology that deals specifically with the catheter-based treatment of structural heart diseases. Interventional cardiology is a non-surgical option which uses a catheter – a small, flexible tube – to repair damaged or weakened vessels, narrowed arteries, or other affected parts of the heart structure.  A large number of procedures can be performed on the heart by catheterization. The main advantages of using the interventional cardiology or radiology approach are the avoidance of the scars and pain, and long post-operative recovery. Additionally, interventional cardiology procedure of primary angioplasty is now the gold standard of care for an acute myocardial infarction.

  • Percutaneous coronary intervention
  • Valvuloplasty
  • Coronary thrombectomy
  • Angiogram
  • Disorders of Heart Valves
  • Ischemic Heart Diseases

 

  • Track 12-1Angiogram
  • Track 12-2Valvuloplasty
  • Track 12-3Coronary thrombectomy
  • Track 12-4Percutaneous coronary intervention
  • Track 12-5Disorders of Heart Valves
  • Track 12-6Ischemic Heart Diseases

Cardiovascular Toxicology deals with the adverse effects on the heart or blood systems which result from exposure to toxic chemicals. It describes safety data of detrimental effects of new cardiovascular drugs. Cardiovascular pharmacology manages the drug of heart illnesses. The Cardiac Drugs are utilized to treat states of the heart or the circulatory or vascular framework. Many classes of cardiovascular operators are accessible to treat the different cardiovascular conditions. Pharmacology of vascular endothelium deals with alterations of endothelial cells and the vasculature play a central role in the pathogenesis of a broad spectrum of the most dreadful of human diseases, as endothelial cells have the key function of participating in the maintenance of patent and functional capillaries.

  • Track 13-1Development of novel anti-ischemic agents
  • Track 13-2Drug-induced cardiac toxicity
  • Track 13-3Novel anti-inflammatory therapies for atherosclerosis

Coronary artery bypass grafting (CABG) is the most usual type of heart surgery. CABG boosts blood flow to the heart. Surgeons make use of CABG to treat people who have critical coronary heart disease (CHD).  For the heart to work well, blood should flow in only one direction. The heart's valves help to make this possible. Healthy valves open and close in a specific way as the heart pumps blood. Each valve has one set of flaps called leaflets. The leaflets open to allow blood to pass from one heart apartment into another or into the arteries. Then the leaflets close tightly to cease blood from flowing backward. Heart surgery is applied to fix leaflets that do not open as wide as they should. This can happen if they become thick or stiff or join together. As a result, not enough blood flows through the valve. This Heart Congress scientific program has been CME and CPD certified.

 

  • Track 14-1Cardiovascular surgery
  • Track 14-2Peripheral vascular surgery
  • Track 14-3 Cardiothoracic surgery
  • Track 14-4 Carotid artery operations
  • Track 14-5Trans-myocardial revascularization (TMR)
  • Track 14-6 Heart valve repair
  • Track 14-7 Coronary artery bypass surgery (CABG)
  • Track 14-8Cardiopulmonary bypass machine
  • Track 14-9 Carotid end arterectomy

Structural heart diseases are structural defects in the heart which may be present from the initial stages of birth, which need to be rectified by surgical interventions. Transcatheter techniques applied for treating non-coronary heart diseases are known as structural heart interventions. New opportunities continue to unfold in the field of treating structural heart interventions. The Present day structural heart intervention training programs include both valvular and non-valvular techniques concentrating on a wide range of adult primary congenital heart defects and complex surgical residual defects infant population. Many cardiologists prefer a new branch of percutaneous treatment which targets congenital and acquired diseases that were not addressed or were treated in another complex manner. Percutaneous structural heart interventions require a multi-axle approach involving cardiac imaging specialistsclinical cardiologistsinterventional cardiologists, pediatricians and expert cardiac surgeons. A thorough assessment on patient procure compatibility has to be made. Continuous enhancement of knowledge and training in materials and devices to be used individual specific procedures is a prerequisite. The catheterization lab in the hospital must be equipped to perform hybrid procedures.

  • Track 15-1Septal defects
  • Track 15-2Valvular heart disease
  • Track 15-3Fistulas
  • Track 15-4Vascular obstructions
  • Track 15-5Any other conditions

Heart disease is a killer that strikes women than men and is more deadly. Women of all ages can be affected with Heart disease. For younger women, the combination of smoking boosts and birth control pills, heart disease risks by 20 percent. In women risk increases with age, certain things like sedentary lifestyle and overeating can cause accumulation of plaque which leads to clogged arteries later.

  • Track 16-1Heart disease and stroke prevention in women
  • Track 16-2Coronary micro vascular disease (MVD)
  • Track 16-3High blood pressure and women
  • Track 16-4Premature atrial contractions
  • Track 16-5Broken heart syndrome
  • Track 16-6Hormone replacement therapy
  • Track 16-7Mental stress and depression

Advances in medicine means that if CHD is detected at the early stage it can be treated successfully to extend survival rate. Successful treatment is more likely if disease is detected at its earliest stages. Our current research work  focuses on the early detection of CHD in order to halt or reverse the progress of the disease. The On-going research includes the  pioneering the use of the  heart scanning in the early diagnosis of heart disease in diabetics and Development of Nuclear Cardiology techniques for the detection of heart disease and  Drug development and evaluation of treatments used in heart disease the  Identification of novel biological markers to predict the presence of  heart disease and Analysis of ethnic and socio-economic differences in heart disease risk.

 

 

  • Track 17-1Cardiovascular Toxicology and Pharmacology
  • Track 17-2Different types of Cardiovascular Drugs
  • Track 17-3Diastolic Heart Failure and Hypertrophic Cardiomyopathy
  • Track 17-4Lipids and Cardiovascular Risk Assessment
  • Track 17-5Clinical Trials in Cardiology
  • Track 17-6Lipids and Cardiovascular Risk Assessment
  • Track 17-7Stroke Prevention

Arrhythmias can develop after a heart attack as a result of damage to the heart muscles. Damaged muscles disrupt electrical signals that control the heart.Some arrhythmias, such as tachycardia, are mild and cause symptoms Other arrhythmias can be life threatening, including:complete heart block, where electrical signals are unable to travel from one side of your heart to the other, so your heart cannot pump blood properly

 

  • Track 18-1Arrhythmias
  • Track 18-2Heart Failure
  • Track 18-3Myocardial Infarction
  • Track 18-4Hypertrophic Cardiomyopathy
  • Track 18-5Angina Pectoris
  • Track 18-6Stroke
  • Track 18-7Aneurysm
  • Track 18-8Atrial Fibrillation

Pharmacology of vascular endothelium deals with modifications of endothelial cells and the vasculature play a crucial part in the pathogenesis of a wide range of the most dreadful of human diseases, as endothelial cells have the vital role of participating in the maintenance of patent and functional capillaries.

  • Track 19-1Neurotoxicology
  • Track 19-2Neurodegenerative Disorders
  • Track 19-3Drug addiction and Alcohol Dependence
  • Track 19-4Circadian Rhythm Disorders

Research advances have contributed to improved outcomes across all specialties, but the rate of advancement in cardiology has been exceptional. Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients' expectations of new drugs and devices. Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modelling and information management issues. We also take a new approach to the way information is structured and delivered, so that its value is maximized to the reader. Accessible 'at-a-glance' formats are important in an increasingly time-constrained clinical community.

Topics include the following areas:

  • Track 20-1Advanced device and imaging technologies
  • Track 20-2Therapeutic overviews highlighting optimal therapy and future options
  • Track 20-3Interventional and surgical approaches
  • Track 20-4New diagnostic approaches, screening and patient stratification
  • Track 20-5Molecular basis of cardiovascular disease
  • Track 20-6Real world evidence and outcomes research

This session plays a significant role in the future of Cardiology research. Cardiology concerns with diseases and disorders of the heart, such as coronary artery disease and congestive heart failure. The Clinical Cardiology includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, vascular heart disease and electrophysiology.

  • Track 21-1Cardio-Oncology
  • Track 21-2Nuclear Cardiology
  • Track 21-3Neonatal Cardiology
  • Track 21-4Sports Cardiology
  • Track 21-5Adult Cardiology
  • Track 21-6Veterinary Cardiology

Cardiology case reports give an appropriate assemblage for all cardiologists by rendering their important clinical cases of late occurrence. Studying from medical cases provides valuable experience for clinicians, students and paramedical staff -members. Rare medical reports and conditions discovered through the latest methods of examination are reinforced. Furthermore, studying diagnostic methods from medical cases and interpretation of symptoms is significant to train and increase the processes which are being used in the clinical field.

  • Track 22-1Case Reports on Hypertension and Healthcare
  • Track 22-2Case Reports on Cardiac Surgery
  • Track 22-3Case Reports on Heart Regeneration
  • Track 22-4Case Reports on Pediatric Cardiology
  • Track 22-5Case Reports on Cardiac and Cardiovascular Research
  • Track 22-6Case Reports on Heart Diagnosis
  • Track 22-7Case Reports on Heart Disease & Failure
  • Track 22-8Case Reports on Arrhythmias
  • Track 22-9Case Reports on Vascular Heart Disease
  • Track 22-10Case Reports on Atherosclerosis